SBI Healthcare Opportunities Fund vs Tata India Pharma & Healthcare Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹4027 Cr | ₹1339 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 32% | 26.49% |
Expense Ratio | 1.94 | 2.14 |
Manager | Pradeep Kesavan | Meeta Shetty |
ISIN Code | INF200K01446 | INF277K016A9 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -0.81% | 1.89% |
6 Month | 9.31% | 11.29% |
1 Year | 11.57% | 5.19% |
3 Year | 26.71% | 23.57% |
5 Year | 20.22% | 18.85% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 3.36% | 5.89% |
1 Year | 7.57% | 8.92% |
3 Year | 25.09% | 23.85% |
5 Year | 21.31% | 19.7% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 16.04% | 10.55% |
3 Year | 17.71% | 18.34% |
5 Year | 12.85% | 15.18% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 13.57% | 15.78% |
Sharp | 1.42% | 1.05% |
Beta | 0.84% | 0.99% |
Alpha | 4.50% | -0.95% |
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Pradeep Kesavan | Meeta Shetty |
Total AUM | ₹434274 Cr | ₹17847 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 12.03 | 8.59 |
Mid Cap | 27.95 | 32.96 |
Small Cap | 33.75 | 30.52 |
Large Cap | 26.26 | 27.92 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 2.38 | 6.22 |
Basic Materials | 5.96 | 0.46 |
Healthcare | 91.66 | 91.69 |
Financial Services | - | 1.63 |
Top Comparisons
WhiteOak Capital Flexi Cap Fund Regular Plan Growth
3Y Returns18.87%
SBI Flexicap Fund - REGULAR PLAN -Growth Option
3Y Returns12.1%
ICICI Prudential Passive Multi-Asset Fund of Funds - Growth
3Y Returns13.79%
Motilal Oswal Asset Allocation FOF- A- Regular Growth
3Y Returns15.04%
ICICI Prudential Nifty Next 50 Index Fund - Growth
3Y Returns16.18%
Nippon India Nifty Smallcap 250 Index Fund - Regular Plan - Growth Option
3Y Returns21.75%
Mahindra Manulife Multi Cap Fund - Regular Plan - Growth
3Y Returns19.51%
Edelweiss Multi Cap Fund - Regular (G)
3Y Returns0%